Allergy Therapeutics
AGY.L
#7292
Rank
NZ$0.48 B
Marketcap
$0.10
Share price
4.97%
Change (1 day)
101.00%
Change (1 year)

Allergy Therapeutics (AGY.L) - Total debt

Total debt on the balance sheet as of December 2023 : NZ$20.28 M

According to Allergy Therapeutics's latest financial reports the company's total debt is NZ$20.28 M. A companyโ€™s total debt is the sum of all current and non-current debts.

Allergy Therapeutics - Total debt on balance sheet (from 2004 to 2023)

Total debt by year

Year Total debt Change
2023-06-30NZ$74.58 M263.83%
2022-06-30NZ$20.5 M-7.15%
2021-06-30NZ$22.07 M-5.61%
2020-06-30NZ$23.39 M408.43%
2019-06-30NZ$4.6 M-22.87%
2018-06-30NZ$5.96 M0.91%
2017-06-30NZ$5.91 M-7.11%
2016-06-30NZ$6.36 M64.92%
2015-06-30NZ$3.85 M3957.56%
2014-06-30NZ$0.09 M-83.19%
2013-06-30NZ$0.56 M-81%
2012-06-30NZ$2.97 M-87.66%
2011-06-30NZ$24.12 M-5.28%
2010-06-30NZ$25.46 M-67.59%
2009-06-30NZ$78.58 M16.27%
2008-06-30NZ$67.59 M1101.08%
2007-06-30NZ$5.62 M
2005-06-30NZ$1.17 M-64.61%
2004-06-30NZ$3.32 M-44.3%
2003-06-30NZ$5.96 M-79.02%
2002-06-30NZ$28.41 M